For children with glucose-6-phosphate dehydrogenase deficiency (G6PD), WHO recommended testing G6PD before prescription of anti-malaria drug to ensure safe administration of primaquine for preventing relapse of P. vivax and P. ovale malaria [12]. Here, G6PD is linked to G6PD deficiency.